Dr. Kaplitt Treats First Patient in New Clinical Trial for Parkinson’s Disease

On June 12, 2021, Dr. Michael Kaplitt treated the first patient in a new clinical trial, “Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD).” In this procedure, Dr. Kaplitt performed an ablation of the pallidothalamic tract (PTT) using high-intensity focused ultrasound to deliver highly targeted ultrasound beams to the PTT to improve motor control in patients with Parkinson’s disease. See slide show and video below, and see the Weill Cornell Medicine JCTO site or clinicaltrials.gov for more about this trial.

In preparation for the procedure, which takes just a few hours, the patient's head is shaved and she is fitted with a headframe to ensure precise beam placement. After multiple pulses, with Dr. Kaplitt checking progress after each one, the patient shows immediate improvement.

Neurological Surgery 525 E. 68th St., Starr 651, Box 99 New York, NY 10065